During the past decade, Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd." #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Dr. Reddy's Laboratories Limited" with 1 trials sponsored, "Horizon Therapeutics Ireland DAC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Viela Bio (acquired by Horizon Therapeutics)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd." #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd." are "Systemic Lupus Erythematosus" (3 trials), "Lupus Erythematosus, Systemic" (1 trials), "Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd." in a lesser frequency.

Most popular intervention types in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd." are "Biological" (3 trials), "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "13-valent Pneumococcal conjugate vaccine" (1 trials), "Blood sample collection" (1 trials) and "DRL_RI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd., 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".